Netherlands· NL-489f68e813ba

Agilus 120 mg poeder voor oplossing voor injectie

A dantrolene product containing dantroleennatrium 3,5-water, registered in Netherlands by Norgine B.V.. The same ATC class is registered in 16 of our 19 countries.

ATC M03CA01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about dantroleennatrium 3,5-waterAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Dantrolene is registered in 16 of 19 countries.

Countries holding a registration under ATC M03CA01 (dantrolene), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search dantrolene products by name

Dantrolene · ATC M03CA01

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dantrolene costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), the median price runs from $1.64 in United States to $5.92 in Finland — a ×3.6 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Dantrolene · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

FI Finland$5.92
US United States$1.64 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: DANTROLEENNATRIUM 3,5-WATER
Manufacturer: Norgine B.V.
Country: Netherlands (NL)
ATC code: M03CA01
ATC class: Dantrolene
Defined daily dose: 0.1 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/24/1805

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

93 interactions on record for dantrolene.

Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check dantrolene against other medicines How interaction checks work

Dantrolene · interactions on record

93 records

16 severe
60 moderate
17 info

Most severe, free to view

Levonorgestrel and ethinylestradiolG03AA07severe
Desogestrel and ethinylestradiolG03AA09severe
Drospirenone and ethinylestradiolG03AA12severe
EthinylestradiolG03CA01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dantrolene in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dantrolene products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

Belgium · Dantrium Iv
Germany · Dantamacrin, Dantrolen I.V.
France · Dantrium, Dantrium Intraveineux
United Kingdom (Northern Ireland) · Agilus, dantrium
Ireland · Dantrium
Iceland · Agilus
Italy · Dantrium
Liechtenstein · Agilus
Norway · Agilus

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f368cb50-e28f-430e-b865-00102a69bc2b
GET /v1/drugs/f368cb50-e28f-430e-b865-00102a69bc2b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder voor oplossing voor injectie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/agilus-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Dantrolene",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp130175",
  "excipients": [
    "HYDROXYPROPYLBETADEX",
    "MACROGOL 3350",
    "STIKSTOF (HEAD SPACE) (E 941)"
  ],
  "substances": [
    "DANTROLEENNATRIUM 3,5-WATER"
  ],
  "leaflet_url": null,
  "authorised_at": "2024/05/29",
  "procedure_number": "EMEA/H/C/006009",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/24/1805",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about dantrolene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console